홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → 3-(5-chloro-4-(4-(methylsulfonamido)phenyl)thiazol-2-yl)-1-(3,3-diphenylpropyl)-1-(2-(piperidin-4-yl)ethyl)urea HCl salt

HRID 2190336
인쇄

반응식

HRID 2190336 반응식
[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:40])[N:9]([CH2:25][CH2:26][CH:27]2[CH2:32][CH2:31][N:30](C(OC(C)(C)C)=O)[CH2:29][CH2:28]2)[CH2:10][CH2:11][CH:12]([C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][CH:14]=2)=[N:4][C:3]=1[C:41]1[CH:46]=[CH:45][C:44]([NH:47][S:48]([CH3:51])(=[O:50])=[O:49])=[CH:43][CH:42]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl>[ClH:1].[Cl:1][C:2]1[S:6][C:5]([NH:7][C:8](=[O:40])[N:9]([CH2:10][CH2:11][CH:12]([C:13]2[CH:14]=[CH:15][CH:16]=[CH:17][CH:18]=2)[C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[CH2:25][CH2:26][CH:27]2[CH2:28][CH2:29][NH:30][CH2:31][CH2:32]2)=[N:4][C:3]=1[C:41]1[CH:42]=[CH:43][C:44]([NH:47][S:48]([CH3:51])(=[O:49])=[O:50])=[CH:45][CH:46]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6422Trifluoroacetic acidHCID 57586321Tert-butyl 4-(2-(3-(5-chloro-4-(4-(methylsulfonamido)phenyl)thiazol-2-yl)-1-(3,3-diphenylpropyl)ureido)ethyl)piperidine-1-carboxylate

생성물 1

HCID 866281263-(5-chloro-4-(4-(methylsulfonamido)phenyl)thiazol-2-yl)-1-(3,3-diphenylpropyl)-1-(2-(piperidin-4-yl)ethyl)urea HCl salt

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

To tert-butyl 4-(2-(3-(5-chloro-4-(4-(methylsulfonamido)phenyl)thiazol-2-yl)-1-(3,3-diphenylpropyl)ureido)ethyl)piperidine-1-carboxylate (0.29 g, 0.4 mmol) dissolved in DCM (2 ml) was added TFA (0.5 ml, 7 mmol). The resulting mixture was stirred at room temperature for 2 hours. After this time the mixture was concentrated under reduced pressure and the residue triturated with diethyl ether. The pale yellow solid was filtered, washed with ether and dried under vacuum. This solid TFA salt was partitioned between DCM and saturated aqueous NaHCO3. The aqueous was re-extracted with DCM (×2). The combined organic extracts were dried over MgSO4 and concentrated up. The residue was taken up in dry DCM and HCl (2M in diethyl ether) was added. The cloudy solution was conc under reduced pressure and dried under high vac to give 3-(5-chloro-4-(4-(methylsulfonamido)phenyl)thiazol-2-yl)-1-(3,3-diphenylpropyl)-1-(2-(piperidin-4-yl)ethyl)urea HCl salt 51 as a pale yellow solid.

후처리

  1. concentrationAfter this time the mixture was concentrated under reduced pressure
  2. customthe residue triturated with diethyl ether
  3. filtrationThe pale yellow solid was filtered
  4. washwashed with ether
  5. customdried under vacuum
  6. customThis solid TFA salt was partitioned between DCM and saturated aqueous NaHCO3
  7. extractionThe aqueous was re-extracted with DCM (×2)
  8. dry with materialThe combined organic extracts were dried over MgSO4
  9. concentrationconcentrated up
  10. additionHCl (2M in diethyl ether) was added
  11. customdried under high vac

출처 및 근거

ORD 기록
ord-d49a17d5b3e14c51b6c1f846696089d7
출처 데이터셋
uspto-grants-2012_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08324396B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트